RXST RXSIGHT INC

RxSight, Inc. to Present at the Needham Healthcare Conference

RxSight, Inc. to Present at the Needham Healthcare Conference

ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Needham Healthcare Conference.

RxSight’s management is scheduled to participate in a fireside chat on Wednesday, April 19, 2023, at 11:15 a.m. Pacific Time / 2:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: .

About RxSight, Inc.

RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery enabling doctors to customize and deliver high-quality of vision to patients after cataract surgery. Additional information about RxSight can be found at .

Company Contact:

Shelley Thunen

RxSight, Inc.

949-521-7830

Investor Relations Contact:



EN
05/04/2023

Underlying

RXSTRXSIGHT INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RXSIGHT INC

 PRESS RELEASE
Free
RXST RXSIGHT INC

RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Gui...

RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance ALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and Recent Developments 2025 Light Adjustable Lens (LAL® and LAL+®) unit sales increased 12% to 109,615Over 300,000 RxSight LAL procedures performed since launch, reinforcing the benefits of post-operative adjustability in clinical practiceLight Delivery Devices (LDD™) installed base expanded to 1,134, providing a strong f...

February 25, 2026 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Re...

RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth quarter and full year 2025 after the market close on Wednesday, February 25, 2026. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conferen...

February 11, 2026 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New...

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2025. In addition, the company provided an update on the previously announced Chief Financial Officer transition. Preliminary Unaudited Fourth Quarter and Full-yea...

January 11, 2026 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: . About RxSight, Inc. RxSigh...

January 2, 2026 1 EN
 PRESS RELEASE
Free
RXST RXSIGHT INC

RxSight, Inc. Announces Chief Financial Officer Transition

RxSight, Inc. Announces Chief Financial Officer Transition ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Company’s Chief Financial Officer, is transitioning from her role. Ms. Thunen will remain with the Company until the sooner of the appointment of her successor or January 31, 2026. Ms. Thunen has agreed to support the Company as a consultant subsequent to the transition. “Shelley has been a k...

December 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch